A quiet shift has been unfolding in beauty conversations. Rather than chasing dramatic transformations, more people are ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Secukinumab 300 mg administered with an auto-injector ...
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the BD Intevia™ 1 mL two-step disposable autoinjector, a robust platform device combining ...
Company anticipates topline data in Q3 2024, followed by a Supplemental New Drug Application (sNDA) by year-end 2024, if successful BURLINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results